Chronic Myelomonocytic Leukemia Prognostic Classification and Management: Evidence Base and Current Practice Dorothée Selimoglu-BuetEric Solary Myeloproliferative Disorders (C Harrison, Section Editor) 21 August 2014 Pages: 301 - 310
Back to Biology: New Insights on Inheritance in Myeloproliferative Disorders Evan M. BraunsteinAlison R. Moliterno Myeloproliferative Disorders (C Harrison, Section Editor) 07 September 2014 Pages: 311 - 318
Antiplatelet Therapy in the Management of Myeloproliferative Neoplasms Alberto Alvarez-LarránCarlos Besses Myeloproliferative Disorders (C Harrison, Section Editor) 14 August 2014 Pages: 319 - 323
Quality of Life in MPN Comes of Age as a Therapeutic Target Robyn M. ScherberHolly L. GeyerRuben A. Mesa Myeloproliferative Disorders (C Harrison, Section Editor) 28 September 2014 Pages: 324 - 330
An Immune Dysregulation in MPN Giovanni Barosi Myeloproliferative Disorders (C Harrison, Section Editor) 20 August 2014 Pages: 331 - 339
Epidemiology of MPN: What Do We Know? L. A. AndersonM. F. McMullin Myeloproliferative Disorders (C Harrison, Section Editor) 17 August 2014 Pages: 340 - 349
Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms A. YacoubO. OdenikeS. Verstovsek Myeloproliferative Disorders (C Harrison, Section Editor) Open access 22 August 2014 Pages: 350 - 359
Controversies in Multiple Myeloma: to Transplant or Not? Isabel Ruth PreeshagulKoen Van BesienTomer M. Mark Multiple Myeloma (R Niesvizky, Section Editor) 22 August 2014 Pages: 360 - 367
Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques Noa BiranScott ElyAjai Chari Multiple Myeloma (R Niesvizky, Section Editor) 16 September 2014 Pages: 368 - 378
What We Mean When We Talk About MRD in Myeloma. A Review of Current Methods. Part 1 of a Two-Part Series Scott ElyNoa BiranAjai Chari Multiple Myeloma (R Niesvizky, Section Editor) 03 October 2014 Pages: 379 - 388
I Walk the Line: How to Tell MDS From Other Bone Marrow Failure Conditions Lukasz P. GondekAmy E. DeZern Myelodysplastic Syndromes (M Sekeres, Section Editor) 31 July 2014 Pages: 389 - 399
I Walk the Other Line: Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndromes Aaron T. Gerds Myelodysplastic Syndromes (M Sekeres, Section Editor) 07 September 2014 Pages: 400 - 406
Lessons from the Atomic Bomb About Secondary MDS Tomoko HataDaisuke ImanishiYasushi Miyazaki Myelodysplastic Syndromes (M Sekeres, Section Editor) 21 September 2014 Pages: 407 - 411
Resuscitating a Dying Marrow: the Role of Hematopoietic Growth Factors Aakriti PanditaSudipto Mukherjee Myelodysplastic Syndromes (M Sekeres, Section Editor) 14 October 2014 Pages: 412 - 420
Stopping Higher-Risk Myelodysplastic Syndrome in Its Tracks Daniel A. PollyeaJonathan A. Gutman Myelodsyplastic Syndromes (M Sekeres, Section Editor) 11 September 2014 Pages: 421 - 431
